SOUTH SAN FRANCISCO, Calif.--(EON: Enhanced Online News)--Solazyme, Inc. (NASDAQ:SZYM) a renewable oil and bioproducts company, announced the November 2011 appointment of Mark Warner as Senior Vice President of Engineering. In this role since November, Mr. Warner is in charge of Engineering for Solazyme, which includes responsibility for the design and construction of Solazyme’s renewable oil and bioproducts production facilities worldwide. He possesses extensive experience in project development of commercial scale facilities and was responsible for the design and construction of the largest biodiesel production facility in the US.
Mr. Warner joins Solazyme from Harris Group where as Senior Vice President of Process Industries he had full management and technical responsibility for billions of dollars of industry leading renewable energy commercialization projects including cellulosic ethanol production plants, micro-algae, macro-algae, biomass power, carbon sequestration and biomass gasification. Clients included many of the top biofuel and biochemical companies, the US Department of Energy (DOE) and the National Renewable Energy Lab (NREL).
Prior to Harris Group, Mr. Warner was Vice President of Engineering for Imperium Renewables. There, he permitted, designed and constructed the largest biodiesel production facility in the US in just 14 months and under budget. His facility successfully passed bank required performance testing and was shown to be the most efficient biodiesel production process commercially available. In addition, he led project development of a multitude of advanced biofuel production facilities in the US, Argentina, Europe, and Asia.
“Mark brings a very senior level of management experience with extensive technological expertise and a proven track record of building out commercial scale success to Solazyme. He is an internationally recognized leader and expert in the area of renewable energy commercialization including facility development, construction and operational deployment. He has been involved in many of the largest plants in the renewable space. I am confident that he will lead Solazyme through this important phase of expansion to commercial production capacity,” said Jonathan Wolfson, Chief Executive Officer of Solazyme.
Mr. Warner is a registered professional engineer with 26 years of broad-ranging business, technical, and management experience in the building and development of renewable energy projects and chemical plant operations. He has actively led site selection, regulatory compliance, permitting, engineering, and project funding efforts for facilities at both U.S. and international sites.
“I am excited to be a part of Solazyme’s world class leadership team and I look forward to working to put steel in the ground and rapidly build out the renewable oil production capacity to meet the demands for these breakthrough tailored oils as the company reaches its next phase in commercialization. This is the most ground breaking, exciting, scalable technology I have worked on in all of my years in the business and it is great to be a part of this dynamic company,” said Mark Warner.
About Solazyme, Inc.
Solazyme, Inc. (NASDAQ: SZYM) is a renewable oil and bioproducts company that transforms a range of low-cost plant-based sugars into high-value oils. Headquartered in South San Francisco, Solazyme’s renewable products can replace or enhance oils derived from the world’s three existing sources – petroleum, plants and animal fats. Initially, Solazyme is focused on commercializing its products into three target markets: (1) fuels and chemicals, (2) nutrition and (3) skin and personal care.
Solazyme®, the Solazyme logo and other trademarks or service names are trademarks of Solazyme, Inc.
This press release contains certain forward-looking statements about Solazyme, Inc., including statements that involve risks and uncertainties concerning the future manufacturing and commercialization plans of Solazyme. When used in this press release, the words “will”, “expects”, “intends” and other similar expressions and any other statements that are not historical facts are intended to identify those assertions as forward-looking statements. Any such statement may be influenced by a variety of factors, many of which are beyond the control of Solazyme, Inc., that could cause actual outcomes and results to be materially different from those projected, described, expressed or implied in this press release due to a number of risks and uncertainties. Potential risks and uncertainties include, among others: Solazyme’s limited operating history; its ability to enter into and maintain strategic collaborations; its ability to obtain requisite regulatory approvals; and its access, on favorable terms, to any required financing. Accordingly, no assurances can be given that any of the events anticipated by the forward-looking statements will transpire or occur, or if any of them do so, what impact they will have on the results of operations or financial condition of Solazyme, Inc.
In addition, please refer to the documents that Solazyme, Inc. files with the Securities and Exchange Commission, including its Quarterly reports on form 10-Q, for a discussion of these and other risks. You are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date of this press release. Solazyme, Inc. is not under any duty to update any of the information in this press release.